Search

everythinglearnresearchcommunity

for

Search:↓

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Chinese kidney transplant patients often feel high blood pressure, hair loss, and tiredness from their medications, and more distress leads to worse medication adherence.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Hair transplants make people look more attractive, successful, approachable, and younger.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Transplant patients often get skin problems, with treatments varying by condition.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

EtG in hair can help detect alcohol use but may be inaccurate in people with certain health conditions.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Peanut allergies can be transferred through organ transplants.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Liver transplant can lead to neurological, pulmonary, cardiovascular, and renal complications, with older patients facing higher risks.